We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.89T
$875M 5.58%
2,600,415
+53,296
+2% +$17.3M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.22T
$561M 3.58%
3,872,500
+160,280
+4% +$23.1M
AAPL icon
3
Apple
AAPL
$4.76T
$537M 3.43%
3,025,972
-352,820
-10% -$55.8M
DHR icon
4
Danaher
DHR
$127B
$297M 1.9%
1,018,441
+111,252
+12% +$30.6M
TMO icon
5
Thermo Fisher Scientific
TMO
$196B
$281M 1.79%
420,792
+54,977
+15% +$34.3M
AMGN icon
6
Amgen
AMGN
$198B
$260M 1.66%
1,157,113
+47,309
+4% +$9.98M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$68.6B
$230M 1.47%
364,586
-24,057
-6% -$14.8M
MRK icon
8
Merck
MRK
$316B
$203M 1.3%
2,652,855
-1,010,324
-28% -$80.5M
NVDA icon
9
NVIDIA
NVDA
$5.18T
$182M 1.16%
6,173,040
+143,900
+2% +$3.96M
UNH icon
10
UnitedHealth
UNH
$394B
$171M 1.09%
341,291
-20,869
-6% -$9.45M
AMZN icon
11
Amazon
AMZN
$2.62T
$169M 1.08%
1,011,560
-13,160
-1% -$2.25M
PG icon
12
Procter & Gamble
PG
$348B
$163M 1.04%
994,965
+156,998
+19% +$23.3M
META icon
13
Meta Platforms (Facebook)
META
$1.59T
$159M 1.01%
471,929
-91,549
-16% -$30.4M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.22T
$154M 0.98%
1,062,600
+33,920
+3% +$4.9M
JNJ icon
15
Johnson & Johnson
JNJ
$613B
$150M 0.96%
875,306
-107,120
-11% -$17.5M
LLY icon
16
Eli Lilly
LLY
$1.03T
$144M 0.92%
522,186
+384,639
+280% +$97.5M
TSLA icon
17
Tesla
TSLA
$1.41T
$144M 0.92%
408,888
+48,060
+13% +$16.1M
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$120B
$142M 0.9%
644,632
+51,803
+9% +$10.1M
SGEN
19
DELISTED
Seagen Inc. Common Stock
SGEN
$137M 0.88%
888,647
+2,623
+0.3% +$439K
WM icon
20
Waste Management
WM
$94.8B
$135M 0.86%
807,595
+190,772
+31% +$30.7M
ADBE icon
21
Adobe
ADBE
$87.3B
$131M 0.83%
230,576
+30,415
+15% +$19M
ADSK icon
22
Autodesk
ADSK
$42.7B
$130M 0.83%
463,105
+100,052
+28% +$29.2M
PYPL icon
23
PayPal
PYPL
$48.9B
$128M 0.82%
678,069
+308,676
+84% +$66.8M
V icon
24
Visa
V
$672B
$127M 0.81%
584,393
+64,164
+12% +$13.8M
BAC icon
25
Bank of America
BAC
$432B
$119M 0.76%
2,681,315
+4,984
+0.2% +$227K
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.